GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Medicus Sciences Acquisition Corp (NAS:MSAC) » Definitions » ROIC %

Medicus Sciences Acquisition (Medicus Sciences Acquisition) ROIC % : -0.75% (As of Sep. 2022)


View and export this data going back to 2021. Start your Free Trial

What is Medicus Sciences Acquisition ROIC %?

ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. Medicus Sciences Acquisition's annualized return on invested capital (ROIC %) for the quarter that ended in Sep. 2022 was -0.75%.

As of today (2024-06-21), Medicus Sciences Acquisition's WACC % is 0.00%. Medicus Sciences Acquisition's ROIC % is 0.00% (calculated using TTM income statement data). Medicus Sciences Acquisition earns returns that do not match up to its cost of capital. It will destroy value as it grows.


Medicus Sciences Acquisition ROIC % Historical Data

The historical data trend for Medicus Sciences Acquisition's ROIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medicus Sciences Acquisition ROIC % Chart

Medicus Sciences Acquisition Annual Data
Trend Dec20 Dec21
ROIC %
- -1.33

Medicus Sciences Acquisition Quarterly Data
Nov20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
ROIC % Get a 7-Day Free Trial -0.73 -0.63 -0.91 -0.76 -0.75

Competitive Comparison of Medicus Sciences Acquisition's ROIC %

For the Shell Companies subindustry, Medicus Sciences Acquisition's ROIC %, along with its competitors' market caps and ROIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medicus Sciences Acquisition's ROIC % Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Medicus Sciences Acquisition's ROIC % distribution charts can be found below:

* The bar in red indicates where Medicus Sciences Acquisition's ROIC % falls into.



Medicus Sciences Acquisition ROIC % Calculation

Medicus Sciences Acquisition's annualized Return on Invested Capital (ROIC %) for the fiscal year that ended in Dec. 2021 is calculated as:

ROIC % (A: Dec. 2021 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (A: Dec. 2020 ) + Invested Capital (A: Dec. 2021 ))/ count )
=-0.615 * ( 1 - 0% )/( (0.213 + 92.158)/ 2 )
=-0.615/46.1855
=-1.33 %

where

Medicus Sciences Acquisition's annualized Return on Invested Capital (ROIC %) for the quarter that ended in Sep. 2022 is calculated as:

ROIC % (Q: Sep. 2022 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2022 ) + Invested Capital (Q: Sep. 2022 ))/ count )
=-0.696 * ( 1 - 0% )/( (92.307 + 92.4)/ 2 )
=-0.696/92.3535
=-0.75 %

where

Note: The Operating Income data used here is four times the quarterly (Sep. 2022) data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medicus Sciences Acquisition  (NAS:MSAC) ROIC % Explanation

ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROIC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, Medicus Sciences Acquisition's WACC % is 0.00%. Medicus Sciences Acquisition's ROIC % is 0.00% (calculated using TTM income statement data).


Be Aware

Like ROE % and ROA %, ROIC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.


Medicus Sciences Acquisition ROIC % Related Terms

Thank you for viewing the detailed overview of Medicus Sciences Acquisition's ROIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Medicus Sciences Acquisition (Medicus Sciences Acquisition) Business Description

Traded in Other Exchanges
N/A
Address
152 West 57th Street, Floor 20, New York, NY, USA, 10019
Medicus Sciences Acquisition Corp is a blank check company.
Executives
Eric Cheng officer: Chief Business Officer 152 WEST 57TH STREET, FLOOR 20, NEW YORK NY 10019
Kenneth Berkovitz director 152 WEST 57TH STREET, FLOOR 20, NEW YORK NY 10019
Christopher Kaster director 152 WEST 57TH STREET, FLOOR 20, NEW YORK NY 10019
Ross Levine director 152 WEST 57TH STREET, FLOOR 20, NEW YORK NY 10019
Judah Drillick officer: Chief Financial Officer 152 WEST 57TH STREET, FLOOR 20, NEW YORK NY 10019
Jacob Gottlieb director, 10 percent owner, officer: Executive Chairman 152 WEST 57TH STREET, FLOOR 20, NEW YORK NY 10019
Medicus Sciences Holdings Llc 10 percent owner 152 WEST 57TH STREET, FLOOR 20, NEW YORK NY 10019
Michael Castor director, 10 percent owner, officer: Chief Executive Officer 152 WEST 57TH STREET, FLOOR 20, NEW YORK NY 10019

Medicus Sciences Acquisition (Medicus Sciences Acquisition) Headlines